Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
42,713,217
-
Share change
-
+1,934,991
-
Total reported value
-
$1,439,533,207
-
Put/Call ratio
-
79%
-
Price per share
-
$33.71
-
Number of holders
-
186
-
Value change
-
+$80,813,352
-
Number of buys
-
106
-
Number of sells
-
70
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q2 2017
As of 30 Jun 2017,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
186 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,713,217 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, HealthCor Management, L.P., Point72 Asset Management, L.P., Tourbillon Capital Partners, L.P., MILLENNIUM MANAGEMENT LLC, Camber Capital Management LLC, PERCEPTIVE ADVISORS LLC, and FMR LLC.
This page lists
186
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.